SCHEMBL21285560

SCHEMBL21285560

N#Cc1cn(C2CCC2)c2nc(N3CCN(c4ccc(C(=O)N5CCC5)cc4)CC3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL3 Q96JM7 3/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ MBTD1 Q05BQ5 1/20 0.41
▸ TP53BP1 Q12888 1/20 0.41
▸ L3MBTL4 Q8NA19 1/20 0.41
▸ MAPT P10636 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MGLL Q99685 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CHRNA10 Q9GZZ6 1/20 0.37
▸ CHRNA9 Q9UGM1 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21274379 0.89 CHRNA10 (0.37) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL21285561 0.89 CHRNA10 (0.37) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL21274083 0.81 MEN1 (0.40) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21274056 0.80 KMT2A (0.40) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL22822815 0.80 TP53 (0.38) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21268737 0.79 MAPT (0.39) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21281509 0.79 MAPT (0.39) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL28503671 0.79 USP2 (0.37) —
SCHEMBL21268734 0.79 MAPT (0.39) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21274187 0.78 MAPT (0.40) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019158731-A1 PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES UCB BIOPHARMA SPRL (BE) 2019-08-22 — — WO disclosed
Send feedback